HPS Pharmacies wish to give notice that Bristol Myers Squibb is experiencing a manufacturing delay for Eliquis® tablets as follows:
This manufacturing delay only affects the packs of 28 tablets. No supply disruption is expected for Eliquis® 5mg in packs of 60 tablets.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Bristol Myers Squibb on 1800 629 273 or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates